{"id":"NCT01746108","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection","officialTitle":"Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06-18","primaryCompletion":"2015-06-29","completion":"2015-06-29","firstPosted":"2012-12-10","resultsPosted":"2017-01-09","lastUpdate":"2019-07-09"},"enrollment":52,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Streptococcal","Streptococcus Pneumoniae Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Synflorix™","otherNames":[]}],"arms":[{"label":"At-risk-Unprimed Group","type":"EXPERIMENTAL"},{"label":"At-risk-Primed Group","type":"EXPERIMENTAL"},{"label":"Healthy-Unprimed Group","type":"ACTIVE_COMPARATOR"},{"label":"Healthy-Primed Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the immunogenicity, safety and reactogenicity of GSK Biologicals' 10Pn-PD-DiT vaccine in children aged between 2 and 17 years of age having asplenia, splenic dysfunction or complement deficiencies.\n\nIn addition, this study will include an age-matched control group of healthy children aged 24-59 months in order to descriptively compare the immunogenicity of 10Pn-PD-DiT vaccine in the at-risk population to that of the general, healthy population one month after each pneumococcal vaccination.","primaryOutcome":{"measure":"Concentrations of Antibodies Against Vaccine Pneumococcal Serotypes in the At Risk Primed Group.","timeFrame":"One month after Dose 1 (At Month 1)","effectByArm":[{"arm":"Synflorix AR-Pr-2-17Y Group","deltaMin":1.94,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":8,"exclusionCount":15},"locations":{"siteCount":6,"countries":["Poland","Russia"]},"refs":{"pmids":["28866290"],"seeAlso":["https://clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":["Pain","Erythema","Swelling","Fatigue","Headache"]}}